HUP0002170A2 - Egy specifikus 5HT2 receptor antagonista alkalmazása alvás közben fellépő apnoe szindróma kezelésére szolgáló gyógyszerkészítmény előállítására - Google Patents

Egy specifikus 5HT2 receptor antagonista alkalmazása alvás közben fellépő apnoe szindróma kezelésére szolgáló gyógyszerkészítmény előállítására

Info

Publication number
HUP0002170A2
HUP0002170A2 HU0002170A HUP0002170A HUP0002170A2 HU P0002170 A2 HUP0002170 A2 HU P0002170A2 HU 0002170 A HU0002170 A HU 0002170A HU P0002170 A HUP0002170 A HU P0002170A HU P0002170 A2 HUP0002170 A2 HU P0002170A2
Authority
HU
Hungary
Prior art keywords
receptors
specific antagonist
disordered breathing
treating sleep
preparing medicines
Prior art date
Application number
HU0002170A
Other languages
English (en)
Inventor
Francoise Cattelin
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of HUP0002170A2 publication Critical patent/HUP0002170A2/hu
Publication of HUP0002170A3 publication Critical patent/HUP0002170A3/hu
Publication of HU229058B1 publication Critical patent/HU229058B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A találmány az (I) képletű vegyület - mely az 5HT2 receptorokspecifikus antagonistájának - alkalmazására vonatkozik az alvás közbenfellépő apnoe szindróma kezelésére szolgáló gyógyszer előállítására. Ó
HU0002170A 1997-06-26 1998-06-02 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing HU229058B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (3)

Publication Number Publication Date
HUP0002170A2 true HUP0002170A2 (hu) 2001-11-28
HUP0002170A3 HUP0002170A3 (en) 2001-12-28
HU229058B1 HU229058B1 (en) 2013-07-29

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002170A HU229058B1 (en) 1997-06-26 1998-06-02 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing

Country Status (29)

Country Link
US (1) US6143792A (hu)
EP (1) EP1014960B1 (hu)
JP (1) JP3503953B2 (hu)
KR (1) KR20010014186A (hu)
CN (1) CN1154485C (hu)
AT (1) ATE232094T1 (hu)
AU (1) AU728227B2 (hu)
BG (1) BG104038A (hu)
BR (1) BR9810337A (hu)
CA (1) CA2295119C (hu)
CZ (1) CZ291935B6 (hu)
DE (1) DE69811248T2 (hu)
EE (1) EE9900595A (hu)
ES (1) ES2191942T3 (hu)
FR (1) FR2765107B1 (hu)
HK (1) HK1028351A1 (hu)
HU (1) HU229058B1 (hu)
ID (1) ID23799A (hu)
IL (1) IL133632A (hu)
IS (1) IS2356B (hu)
NO (1) NO325520B1 (hu)
NZ (1) NZ502495A (hu)
PL (1) PL190723B1 (hu)
RU (1) RU2218917C2 (hu)
SK (1) SK283845B6 (hu)
TR (1) TR199903197T2 (hu)
TW (1) TW580386B (hu)
UA (1) UA59397C2 (hu)
WO (1) WO1999000119A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
PT1066036E (pt) * 1998-02-27 2006-09-29 Univ Illinois Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
US6548082B1 (en) * 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
CN1305871C (zh) * 2002-07-19 2007-03-21 比奥维特罗姆股份公司 用于治疗与5－ht2a受体有关疾病的新哌嗪基－吡嗪酮衍生物
CA2590802A1 (en) 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2365805A1 (en) * 2008-11-13 2011-09-21 Sanofi Method of treating sleep disorders using eplivanserin
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA912278B (en) * 1990-03-29 1992-11-25 Lilly Co Eli Compounds affecting serotonin receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
BR9810337A (pt) 2000-09-05
ID23799A (id) 2000-05-11
NO996442L (no) 2000-02-28
ATE232094T1 (de) 2003-02-15
CN1154485C (zh) 2004-06-23
HU229058B1 (en) 2013-07-29
PL190723B1 (pl) 2005-12-30
ES2191942T3 (es) 2003-09-16
TW580386B (en) 2004-03-21
HK1028351A1 (en) 2001-02-16
NO325520B1 (no) 2008-06-02
EP1014960B1 (fr) 2003-02-05
EP1014960A1 (fr) 2000-07-05
AU728227B2 (en) 2001-01-04
US6143792A (en) 2000-11-07
SK283845B6 (sk) 2004-03-02
CN1265586A (zh) 2000-09-06
JP3503953B2 (ja) 2004-03-08
IL133632A (en) 2003-10-31
JP2001520678A (ja) 2001-10-30
TR199903197T2 (xx) 2000-05-22
NZ502495A (en) 2000-10-27
FR2765107A1 (fr) 1998-12-31
AU8024398A (en) 1999-01-19
DE69811248T2 (de) 2003-12-04
CA2295119A1 (en) 1999-01-07
CZ291935B6 (cs) 2003-06-18
IS2356B (is) 2008-04-15
SK184599A3 (en) 2000-06-12
EE9900595A (et) 2000-08-15
NO996442D0 (no) 1999-12-23
KR20010014186A (ko) 2001-02-26
WO1999000119A1 (fr) 1999-01-07
FR2765107B1 (fr) 2000-03-24
UA59397C2 (uk) 2003-09-15
BG104038A (en) 2001-04-30
IL133632A0 (en) 2001-04-30
IS5316A (is) 1999-12-21
HUP0002170A3 (en) 2001-12-28
DE69811248D1 (de) 2003-03-13
PL337871A1 (en) 2000-09-11
CZ469599A3 (cs) 2000-04-12
CA2295119C (en) 2007-02-13
RU2218917C2 (ru) 2003-12-20

Similar Documents

Publication Publication Date Title
HUP0002170A2 (hu) Egy specifikus 5HT2 receptor antagonista alkalmazása alvás közben fellépő apnoe szindróma kezelésére szolgáló gyógyszerkészítmény előállítására
CY1105729T1 (el) Παραγοντες με σχετιζομενη με σεροτονινη δραση για την αντιμετωπιση για υπνικη απνοια
HUP0003750A2 (hu) Gyógyszerkészítmények
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
BR0315846A (pt) Tratamento farmacológico para apnéia do sono
HUP0100080A2 (hu) Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására
JP2005512965A5 (hu)
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
HUP0200969A3 (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders os mixed anxiety-depression disorders
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
DE69209140D1 (de) Verwendung Glycine/NMDA-Rezeptorliganden zur Herstellung eines Arzneimittels zur Behandlung von Drogenabhängigkeit und Entzugserscheinungen
EE200200088A (et) Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
HUP0001913A2 (hu) Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására
HUP0401798A2 (hu) Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására
ATE267612T1 (de) Verwendung von vogel-antikörpern
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
DE69906728D1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
IL143143A0 (en) USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS
BR0112874A (pt) Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva
NO970431L (no) Tetrahydroisokinolin-derivater
DE60022047D1 (de) Antivirale therapie

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees